Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox for Stomach Cancer Treatment
NCT01822210Phase 2Completed
- Sponsor
- St. Olavs University Hospital
- Start
- Jan 2013
- Primary completion
- May 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in gastric adenocarcinoma, sponsored by St. Olavs University Hospital. Started Jan 2013; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on NCT01822210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01822210.